Resonate-2 Study Propels Other Studies using Ibrutnib in Combination Therapy

Paul Barr, MD of University of Rochester, discusses the use of ibrutinib in combination therapy from Resonate-2 Study at the 58th ASH Annual Meeting in San Diego, CA.